Post Blogs, Photos, Youtube, Vimeo Videos, Topics, Events, Groups.
+ Larger Font | - Smaller Font

Welcome to Robins Social Network

Be part of the community and join us today!

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; majority of these tests are intended to facilitate important therapy-related decisions, claims Roots Analysis

Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.


To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this link


The USD  860 million (by 2030) financial opportunity within the cancer biomarkers market has been analyzed across the following segments:

§  Type of test

§  Laboratory Developed Tests (LDTs)

§  Companion Diagnostic Tests (CDx)


§  Type of disease indication

§  Breast cancer

§  Blood cancer

§  Colon / Colorectal cancer

§  Lung Cancer

§  Melanoma

§  Prostate Cancer


§  Type of cancer biomarker

§  TMB

§  MSI / MMR

§  TILs


§  Type of analytical technique

§  Next Generation Sequencing (NGS)

§  Polymerase Chain Reaction (PCR)

§  Immunohistochemistry (IHC)

§  Others


§  Key geographical regions

§  North America

§  Europe

§  Japan

§  China

§  Australia


The Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030report features the following companies, which we identified to be key players in this domain:

§  Foundation Medicine

§  NeoGenomics Laboratories

§  Novogene

§  Q2 Solutions

§  Personal Genome Diagnostics

§  Dr Lal PathLabs

§  Shenzhen Yuce Biotechnology


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Product Competitiveness Analysis

6. Company Profiles

7. Publication Analysis 

8. Innovative Designs for Biomarker-Based Clinical Trials

9. Clinical Trial Analysis

10. Market Forecast

11. Future Growth Opportunities

12. Case Study: Analysis of Needs of Stakeholders in The Companion Diagnostics Industry

13. Case Study: Analysis of Value Chain in the Companion Diagnostics Industry

14. Clinical Research on Cancer Biomarkers: A Big Pharma Perspective


15. Executive Insights


16. Appendix 1: Tabulated Data


17. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415 


on January 27 at 6:33

Comments (0)

Become a member and experience a unique opportunity to post blogs, photos, Youtube Vimeo videos, topics, events, and create groups on Robin's Social Networking Site. Use Robin's Social to sell products, services and market your business when posting blogs.

By registering and posting content, you agree to the terms listed at... Posting Terms and Conditions. Enjoy!

© 2022 Content By Members. All Rights Reserved.